Europe’s October mosquito reports do not show one outbreak. They show three surveillance systems describing three different patterns of local transmission.
As of September 30, ECDC recorded 65 locally acquired dengue cases in mainland Europe: 59 in Italy and six in France. Italy’s cases were distributed across nine clusters, all listed as active; 12 cases and two clusters were new since the previous update. France reported one additional case, but none of its four clusters remained active (ECDC dengue surveillance, Week 40).
The chikungunya map was larger. France had reported 124 locally acquired cases across 19 clusters, including 34 new cases since the previous week. Seventeen clusters were active, and the largest included 30 cases in Prignac-et-Marcamps. Italy had reported one locally acquired case in Rome, with the associated cluster still active (ECDC chikungunya surveillance, Week 40).
West Nile virus produced a different regional footprint: 1,765 locally acquired human infections across 202 affected areas in 16 countries. Italy reported the largest national count at 721, followed by Greece at 420. Sixteen areas were identified as affected for the first time in the latest week (ECDC West Nile surveillance, published October 2).
Those figures should not be placed in a single ranking without context. Dengue and chikungunya are primarily transmitted by Aedes mosquitoes, while West Nile transmission is associated mainly with Culex mosquitoes and a bird–mosquito cycle. Surveillance definitions also differ. ECDC’s West Nile weekly map is explicitly designed to support blood and other substances-of-human-origin safety decisions and defines an affected area after at least one locally acquired human case. Dengue and chikungunya reports organize cases into clusters that can later be closed after a defined period without new onset.
The shared story is that local mosquito-borne transmission is no longer an abstract travel-health concern for Europe. The separate stories are where transmission is active, which mosquitoes are involved, who is most likely to develop severe disease and which public-health controls are appropriate.
For dengue and chikungunya, cluster detection can prompt local vector control, case finding and public communication. West Nile surveillance has an additional immediate connection to blood safety: authorities may defer or test donors with exposure in affected areas. The count of “affected areas” is therefore not simply another way of stating the number of sick people.
Seasonal data also require humility. Reported cases are not the same as all infections. People with mild or no symptoms may never be tested. Countries differ in surveillance intensity, and recent cases may arrive late in the data. ECDC labels these weekly systems as surveillance tools, not complete measurements of every infection.
What is fact: the submitted case totals, affected areas, clusters and active-status labels reported by ECDC through September 30.
What is analysis: the conclusion that Europe should plan for a multi-disease mosquito preparedness problem rather than one generalized “tropical disease” threat.
What remains uncertain: the eventual size and duration of transmission, the degree of under-detection and how weather will shape the remaining season.
The clearest way to read the three maps is together, then separately. Together, they show that Europe’s vector landscape is changing. Separately, they tell public-health teams what action the data can actually support.
Persona disclosure. Maya Bell is a recurring fictional TiPH editorial persona. Her work is researched and edited under Today in Public Health’s editorial standards; she is not a real-world correspondent or quoted source.
Related on TiPH: Global Signal Scan, October 2, 2026 · Latest news · How we verify signals